Empowered by vaccination, regular screening, and healthy choices, women can replace fear with action—transforming cervical ...

Michele Hoaglund, who bought the store about a decade ago from its founding owners, was diagnosed with ovarian cancer around ...

Experts studying the health risks of talc have prompted the U.S. Food and Drug Administration to reevaluate its presence in ...

Certain HPV vaccines prevent cancers of the cervix, vulva, vagina, and anus. The time to get vaccinated is between ages 9 and ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

Adding relacorilant to nab-paclitaxel improved survival outcomes in patients with platinum-resistant ovarian cancer.

Pancreatic cancer is a very serious illness that starts in the pancreas, a small organ behind the stomach. The pancreas helps ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

Within weeks of treating patients with CER-1236, the company hopes to start learning about its safety profile and gauge efficacy markers.

Brian Slomovitz, MD, of Mount Sinai Medical Center, compares relacorilant plus nab-paclitaxel with existing treatments for platinum-resistant ovarian cancer and highlights the ROSELLA trial’s global ...

Adding dostarlimab to platinum-based chemotherapy and niraparib improved PFS in patients with advanced ovarian cancer.